Evidence map›Paper›PMID 41502391›Full record

ArticleBiometrics2026

Learning optimal early decision treatment rules with multi-domain intermediate outcomes.

Wenbo Fei, Yuan Chen, Zexi Cai, Donglin Zeng, Yuanjia Wang

Abstract read
In one paragraph

Article in Biometrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wenbo FeiDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.ORCID 0009-0000-6377-3252
Yuan ChenDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-8734-007X
Zexi CaiDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.ORCID 0000-0002-0253-8045
Donglin ZengDepartment of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA.
Yuanjia WangDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.ORCID 0000-0002-1510-3315

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Statistical Methods for Integrating Mixed-type Biomarkers and Phenotypes in Neurodegenerative Disease ModelingR01NS073671 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2011 to 2025
$3.9M
Statistical and Machine Learning Methods to Improve Dynamic Treatment Regimens Estimation Using Real World Data.R01GM124104 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Yuanjia Wang, Donglin Zeng · 2018 to 2026
$3.1M
Machine Learning Methods for Optimizing Individualized Treatment Strategies for Precision PsychiatryR01MH123487 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2021 to 2025
$2.0M
NCI NIH HHS P30 CA008748NIGMS NIH HHS R01 GM124104NIMH NIH HHS R01 MH123487NINDS NIH HHS R01 NS073671U.S. National Institute of Health GM124104U.S. National Institute of Health MH123487U.S. National Institute of Health NS073671
6 · The paper itself

Abstract

Implementing precision medicine for mental disorders presents challenges due to disease complexity and heterogeneity in patient responses. Empirical studies suggest that early indicators, such as interim measures (e.g., interim patient self-reports) of disease improvement or relapse, can predict longer-term outcomes, serving as proxies when final outcomes (e.g., in-clinic assessments) are less accessible. However, existing approaches for deriving individualized treatment rules (ITRs) often ignore these early signals, instead focusing only on a final outcome as the reward. In this work, we propose a new method incorporating intermediate outcomes from various domains into a personalized composite outcome, serving as the reward for learning ITRs. This composite is a weighted sum of inferred latent states from observed measures, with weights personalized for each patient, ensuring consistency with the long-term final response. Our simulations show that this approach not only provides early detection of non-responders but also improves long-term treatment outcomes. Applying our framework to a randomized clinical trial on major depressive disorder (MDD) demonstrates its effectiveness and advantages in ITR learning.

Indexed as

Machine LearningPrecision MedicineComputer SimulationHumansMajor Depressive DisorderRandomized Controlled Trials as TopicTreatment OutcomeClinical trialsMachine learningMental disordersPersonalized healthcarePersonalized rewardPrecision medicine

Identifiers

PMID41502391
PMCPMC12885172

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.